Sumitomo Pharma Q1 FY27 net profit rises 51.7% to JPY 17 billion; revenue increases 19.9% to JPY 129.5 billion

Reuters2026/07/31 06:36

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sumitomo Pharma posted Q1 revenue of JPY 129.5 billion, up 19.9% from a year earlier.
Operating profit slipped 10.8% to JPY 18.19 billion, while core operating profit fell 11% to JPY 18.13 billion.
Net profit more than doubled to JPY 17 billion, lifting basic earnings per share to JPY 39.02.
It introduced a half-year forecast for revenue of JPY 251 billion, operating profit of JPY 30 billion, net profit attributable to owners of the parent of JPY 26 billion.
It maintained its full-year outlook for revenue of JPY 540 billion, operating profit of JPY 90 billion, net profit attributable to owners of the parent of JPY 77 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sumitomo Pharma Co. Ltd. published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sumitomo Pharma Q1 FY27 net profit rises 51.7% to JPY 17 billion; revenue increases 19.9% to JPY 129.5 billion

You may also like

Crypto prices